What a disappointing turn of event. Most disappointing is not seeing any director buys even at these levels.A few director buys would surely show confidence and also may help stop the bleed.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game